Clearside Biomedical SG&A Expense (Quarterly) Insights

Clearside Biomedical Inc (CLSD)

1.34 +0.02 (+1.52%) USD | NASDAQ | May 03, 10:23

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	2.947M
September 30, 2023	2.637M
June 30, 2023	3.127M
March 31, 2023	3.158M
December 31, 2022	3.169M
September 30, 2022	2.353M
June 30, 2022	2.791M
March 31, 2022	3.457M
December 31, 2021	3.14M
September 30, 2021	2.816M
June 30, 2021	2.816M
March 31, 2021	2.893M
December 31, 2020	2.649M
September 30, 2020	2.374M
June 30, 2020	2.611M
March 31, 2020	3.122M
December 31, 2019	3.65M
September 30, 2019	3.781M
June 30, 2019	5.004M

Date	Value
March 31, 2019	4.384M
December 31, 2018	4.176M
September 30, 2018	3.873M
June 30, 2018	3.561M
March 31, 2018	3.074M
December 31, 2017	2.441M
September 30, 2017	2.298M
June 30, 2017	2.29M
March 31, 2017	2.671M
December 31, 2016	2.391M
September 30, 2016	1.629M
June 30, 2016	0.97M
March 31, 2016	1.273M
December 31, 2015	1.218M
September 30, 2015	1.065M
June 30, 2015	3.023M
March 31, 2015	1.249M
December 31, 2014	0.733M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.353M

Minimum

Sep 2022

5.004M

Maximum

Jun 2019

3.079M

Average

2.947M

Median

Dec 2023

SG&A Expense (Quarterly) Benchmarks